NBIS vs. NVO

Last updated Jun 9, 2026

NBIS (Nebius Group N.V.) and NVO (Novo Nordisk A/S) are both stocks. NBIS operates in Internet Content & Information (Communication Services), while NVO operates in Drug Manufacturers - General (Healthcare). Over the past year, NBIS returned 351.53% vs -42.47% for NVO. At a 0.17 correlation, their price movements are largely independent.

Performance

NBIS vs. NVO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Nebius Group N.V. (NBIS) and Novo Nordisk A/S (NVO). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, NBIS achieves a 160.44% return, which is significantly higher than NVO's -16.56% return.

NBIS

• 1D: -4.31%
• 1M: 23.13%
• YTD: 160.44%
• 6M: 117.28%
• 1Y: 351.53%
• 3Y*: —
• 5Y*: —
• 10Y*: —

NVO

• 1D: -4.52%
• 1M: -10.96%
• YTD: -16.56%
• 6M: -9.23%
• 1Y: -42.47%
• 3Y*: -17.53%
• 5Y*: 1.78%
• 10Y*: 6.20%

*Multi-year figures are annualized to reflect compound growth (CAGR)

NBIS vs. NVO - Yearly Performance Comparison

	2026 (YTD)	2025	2024
NBIS Nebius Group N.V.	160.44%	202.18%	46.25%
NVO Novo Nordisk A/S	-16.56%	-39.22%	-27.16%

Correlation

The correlation between NBIS and NVO is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.21
Correlation (All Time) Calculated using the full available price history since Oct 21, 2024	0.17

Fundamentals

Market Cap NBIS : $67.36B NVO : $182.49B
EPS NBIS : $3.17 NVO : $27.42
PE Ratio NBIS : 68.67 NVO : 1.50
PEG Ratio NBIS : 23.59 NVO : 0.06
PS Ratio NBIS : 65.42 NVO : 0.56
PB Ratio NBIS : 9.30 NVO : 0.90
Total Revenue (TTM) NBIS : $877.90M NVO : $327.80B
Gross Profit (TTM) NBIS : $420.60M NVO : $268.30B
EBITDA (TTM) NBIS : -$52.78M NVO : $181.54B

Return for Risk

NBIS vs. NVO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NBIS

NBIS Risk / Return Rank: 94
NBIS Sharpe Ratio Rank: 96
NBIS Sortino Ratio Rank: 94
NBIS Omega Ratio Rank: 90
NBIS Calmar Ratio Rank: 96
NBIS Martin Ratio Rank: 95

NVO

NVO Risk / Return Rank: 12
NVO Sharpe Ratio Rank: 9
NVO Sortino Ratio Rank: 12
NVO Omega Ratio Rank: 10
NVO Calmar Ratio Rank: 13
NVO Martin Ratio Rank: 17

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NBIS vs. NVO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Nebius Group N.V. (NBIS) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	NBIS	NVO	Difference
Sharpe ratio: Return per unit of total volatility	3.39	-0.82	+4.21
Sortino ratio: Return per unit of downside risk	3.71	-1.01	+4.71
Omega ratio: Gain probability vs. loss probability	1.41	0.86	+0.55
Calmar ratio: Return relative to maximum drawdown	7.79	-0.77	+8.57
Martin ratio: Return relative to average drawdown	17.86	-1.14	+19.01
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

NBIS vs. NVO - Sharpe Ratio Comparison

The current NBIS Sharpe Ratio is 3.39, which is higher than the NVO Sharpe Ratio of -0.82. The chart below compares the historical Sharpe Ratios of NBIS and NVO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	NBIS	NVO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	3.39	-0.82	+4.21
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.05	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.19	—
Sharpe Ratio (All Time) Calculated using the full available price history	3.19	0.47	+2.72

Drawdowns

NBIS vs. NVO - Drawdown Comparison

The maximum NBIS drawdown since its inception was -58.27%, smaller than the maximum NVO drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for NBIS and NVO.

Drawdown Indicators

	NBIS	NVO	Difference
Max Drawdown Largest peak-to-trough decline	-58.27%	-74.70%	+16.43%
Max Drawdown (1Y) Largest decline over 1 year	-45.47%	-55.03%	+9.56%
Max Drawdown (3Y) Largest decline over 3 years	—	-74.70%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-74.70%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-74.70%	—
Current Drawdown Current decline from peak	-17.58%	-70.19%	+52.61%
Average Drawdown Average peak-to-trough decline	-19.02%	-17.77%	-1.25%
Ulcer Index Depth and duration of drawdowns from previous peaks	19.79%	37.21%	-17.42%

Volatility

NBIS vs. NVO - Volatility Comparison

Nebius Group N.V. (NBIS) has a higher volatility of 33.60% compared to Novo Nordisk A/S (NVO) at 9.75%. This indicates that NBIS's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	NBIS	NVO	Difference
Volatility (1M) Calculated over the trailing 1-month period	33.60%	9.75%	+23.85%
Volatility (6M) Calculated over the trailing 6-month period	71.53%	38.30%	+33.23%
Volatility (1Y) Calculated over the trailing 1-year period	104.78%	52.08%	+52.70%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	110.72%	38.31%	+72.41%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	110.72%	32.56%	+78.16%

Dividends

NBIS vs. NVO - Dividend Comparison

NBIS has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 4.39%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
NBIS Nebius Group N.V.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NVO Novo Nordisk A/S	4.39%	3.31%	1.68%	1.00%	1.20%	1.35%	1.87%	2.14%	1.45%	1.52%	2.87%	0.92%

Financials

Frequently Asked Questions

Can I hold both NBIS and NVO in my portfolio?

NBIS and NVO have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, NBIS or NVO?

NBIS has higher volatility (33.60%) compared to NVO (9.75%). In terms of maximum drawdown, NBIS dropped -58.27% vs NVO's -74.70%.

Which has better risk-adjusted returns?

NBIS currently has the higher Sharpe Ratio (3.39 vs -0.82), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.